115 related articles for article (PubMed ID: 24704613)
1. Design and synthesis of a hybrid series of potent and selective agonists of α7 nicotinic acetylcholine receptor.
Nencini A; Castaldo C; Comery TA; Dunlop J; Genesio E; Ghiron C; Haydar S; Maccari L; Micco I; Turlizzi E; Zanaletti R; Zhang J
Eur J Med Chem; 2014 May; 78():401-18. PubMed ID: 24704613
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a novel alpha-7 nicotinic acetylcholine receptor agonist series and characterization of the potent, selective, and orally efficacious agonist 5-(4-acetyl[1,4]diazepan-1-yl)pentanoic acid [5-(4-methoxyphenyl)-1H-pyrazol-3-yl] amide (SEN15924, WAY-361789).
Zanaletti R; Bettinetti L; Castaldo C; Cocconcelli G; Comery T; Dunlop J; Gaviraghi G; Ghiron C; Haydar SN; Jow F; Maccari L; Micco I; Nencini A; Scali C; Turlizzi E; Valacchi M
J Med Chem; 2012 May; 55(10):4806-23. PubMed ID: 22468936
[TBL] [Abstract][Full Text] [Related]
3. Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).
Ghiron C; Haydar SN; Aschmies S; Bothmann H; Castaldo C; Cocconcelli G; Comery TA; Di L; Dunlop J; Lock T; Kramer A; Kowal D; Jow F; Grauer S; Harrison B; La Rosa S; Maccari L; Marquis KL; Micco I; Nencini A; Quinn J; Robichaud AJ; Roncarati R; Scali C; Terstappen GC; Turlizzi E; Valacchi M; Varrone M; Zanaletti R; Zanelli U
J Med Chem; 2010 Jun; 53(11):4379-89. PubMed ID: 20465311
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of 1,4-Diazobicylco[3.2.2]nonane derivatives as α7-Nicotinic acetylcholine receptor PET/CT imaging agents and agonists for Alzheimer's disease.
Wang S; Fang Y; Wang H; Gao H; Jiang G; Liu J; Xue Q; Qi Y; Cao M; Qiang B; Zhang H
Eur J Med Chem; 2018 Nov; 159():255-266. PubMed ID: 30296684
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activities of indolizine derivatives as alpha-7 nAChR agonists.
Xue Y; Tang J; Ma X; Li Q; Xie B; Hao Y; Jin H; Wang K; Zhang G; Zhang L; Zhang L
Eur J Med Chem; 2016 Jun; 115():94-108. PubMed ID: 26994846
[TBL] [Abstract][Full Text] [Related]
6. N-[5-(5-fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): a medicinal chemistry effort toward an α7 nicotinic acetylcholine receptor agonist preclinical candidate.
Zanaletti R; Bettinetti L; Castaldo C; Ceccarelli I; Cocconcelli G; Comery TA; Dunlop J; Genesio E; Ghiron C; Haydar SN; Jow F; Maccari L; Micco I; Nencini A; Pratelli C; Scali C; Turlizzi E; Valacchi M
J Med Chem; 2012 Nov; 55(22):10277-81. PubMed ID: 23083093
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of a novel series of 4-heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 nicotinic receptor agonists 2. Development of 4-heteroaryl SAR.
Iwuagwu C; King D; McDonald IM; Cook J; Zusi FC; Hill MD; Mate RA; Fang H; Knox R; Gallagher L; Post-Munson Amy Easton D; Miller R; Benitex Y; Siuciak J; Lodge N; Zaczek R; Morgan D; Bristow L; Macor JE; Olson RE
Bioorg Med Chem Lett; 2017 Mar; 27(5):1261-1266. PubMed ID: 28169167
[TBL] [Abstract][Full Text] [Related]
8. [The structure-activity relationships of novel α7 nicotinic acetylcholine receptor agonists based on indolizine scaffold].
Li Q; Yang TY; Xue Y; Ma XZ; Tang JS; Zhang GS; Wang KW; Zhang LR
Yao Xue Xue Bao; 2016 Oct; 51(10):1584-94. PubMed ID: 29932605
[TBL] [Abstract][Full Text] [Related]
9. Design of α7 nicotinic acetylcholine receptor ligands in quinuclidine, tropane and quinazoline series. Chemistry, molecular modeling, radiochemistry, in vitro and in rats evaluations of a [(18)F] quinuclidine derivative.
Pin F; Vercouillie J; Ouach A; Mavel S; Gulhan Z; Chicheri G; Jarry C; Massip S; Deloye JB; Guilloteau D; Suzenet F; Chalon S; Routier S
Eur J Med Chem; 2014 Jul; 82():214-24. PubMed ID: 24904968
[TBL] [Abstract][Full Text] [Related]
10. Development of spiroguanidine-derived α7 neuronal nicotinic receptor partial agonists.
Hill MD; Fang H; Digavalli SV; Healy FL; Gallagher L; Post-Munson D; Chen P; Natale J; Benitex Y; Morgan D; Lodge N; Bristow L; Macor JE; Olson RE
Bioorg Med Chem Lett; 2017 Feb; 27(3):578-581. PubMed ID: 27993517
[TBL] [Abstract][Full Text] [Related]
11. Discovery of fused heterocyclic carboxamide derivatives as novel α7-nAChR agonists: Synthesis, preliminary SAR and biological evaluation.
Xue Y; He X; Yang T; Wang Y; Liu Z; Zhang G; Wang Y; Wang K; Zhang L; Zhang L
Eur J Med Chem; 2019 Nov; 182():111618. PubMed ID: 31434041
[TBL] [Abstract][Full Text] [Related]
12. Aminobenzisoxazole compounds as agonists of α7 nicotinic acetylcholine receptors: a patent evaluation (WO 2017027600).
He Y; Shen J
Expert Opin Ther Pat; 2018 May; 28(5):429-436. PubMed ID: 29566578
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel 2-((pyridin-3-yloxy)methyl)piperazines as α7 nicotinic acetylcholine receptor modulators for the treatment of inflammatory disorders.
Clark RB; Lamppu D; Libertine L; McDonough A; Kumar A; LaRosa G; Rush R; Elbaum D
J Med Chem; 2014 May; 57(10):3966-83. PubMed ID: 24814197
[TBL] [Abstract][Full Text] [Related]
14. Design of α7 nicotinic acetylcholine receptor ligands using the (het)Aryl-1,2,3-triazole core: Synthesis, in vitro evaluation and SAR studies.
Ouach A; Pin F; Bertrand E; Vercouillie J; Gulhan Z; Mothes C; Deloye JB; Guilloteau D; Suzenet F; Chalon S; Routier S
Eur J Med Chem; 2016 Jan; 107():153-64. PubMed ID: 26580980
[TBL] [Abstract][Full Text] [Related]
15. Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders.
Roncarati R; Scali C; Comery TA; Grauer SM; Aschmi S; Bothmann H; Jow B; Kowal D; Gianfriddo M; Kelley C; Zanelli U; Ghiron C; Haydar S; Dunlop J; Terstappen GC
J Pharmacol Exp Ther; 2009 May; 329(2):459-68. PubMed ID: 19223665
[TBL] [Abstract][Full Text] [Related]
16. Investigations of amide bond variation and biaryl modification in analogues of α7 nAChR agonist SEN12333.
Beinat C; Reekie T; Hibbs D; Xie T; Olson TT; Xiao Y; Harvey A; O'Connor S; Coles C; Tsanaktsidis J; Kassiou M
Eur J Med Chem; 2014 Sep; 84():200-5. PubMed ID: 25019477
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel positive allosteric modulators of the α7 nicotinic acetylcholine receptor: Scaffold hopping approach.
Ledneczki I; Tapolcsányi P; Gábor E; Visegrády A; Vass M; Éles J; Holm P; Horváth A; Pocsai A; Mahó S; Greiner I; Krámos B; Béni Z; Kóti J; Káncz AE; Thán M; Kolok S; Laszy J; Balázs O; Bugovits G; Nagy J; Vastag M; Szájli Á; Bozó É; Lévay G; Lendvai B; Némethy Z
Eur J Med Chem; 2021 Mar; 214():113189. PubMed ID: 33540354
[TBL] [Abstract][Full Text] [Related]
18. Novel 5-(quinuclidin-3-ylmethyl)-1,2,4-oxadiazoles to investigate the activation of the α7 nicotinic acetylcholine receptor subtype: Synthesis and electrophysiological evaluation.
Quadri M; Silnović A; Matera C; Horenstein NA; Stokes C; De Amici M; Papke RL; Dallanoce C
Eur J Med Chem; 2018 Dec; 160():207-228. PubMed ID: 30342362
[TBL] [Abstract][Full Text] [Related]
19. The Recent Development of α7 Nicotinic Acetylcholine Receptor (nAChR) Ligands as Therapeutic Candidates for the Treatment of Central Nervous System (CNS) Diseases.
Beinat C; Banister SD; Herrera M; Kassiou M
Curr Pharm Des; 2016; 22(14):2134-51. PubMed ID: 26818858
[TBL] [Abstract][Full Text] [Related]
20. EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors.
Prickaerts J; van Goethem NP; Chesworth R; Shapiro G; Boess FG; Methfessel C; Reneerkens OA; Flood DG; Hilt D; Gawryl M; Bertrand S; Bertrand D; König G
Neuropharmacology; 2012 Feb; 62(2):1099-110. PubMed ID: 22085888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
